Literature DB >> 2501580

Comparison of ornithine metabolism in hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome, lysinuric protein intolerance and gyrate atrophy fibroblasts.

J Botschner1, D W Smith, O Simell, C R Scriver.   

Abstract

We measured L-ornithine oxidation in cultured skin fibroblasts from seven patients with hyperornithinaemia-hyperammonaemia-homocitrullinuria (HHH) syndrome (McKusick 23897), and compared it with oxidation by ornithine aminotransferase deficient gyrate atrophy (McKusick 25887) cells and lysinuric protein intolerance (McKusick 22270) cells in which there is an ornithine transport abnormality at the plasma membrane. Net uptake of ornithine is not abnormal in intact HHH cells. Ornithine oxidation was depressed in HHH and gyrate atrophy cells but not in lysinuric protein intolerance cells; the latter finding suggests there is no significant mitochondrial defect in lysinuric protein intolerance cells. Since HHH cells have intact ornithine aminotransferase, impaired oxidation is compatible with deficient penetration of ornithine into mitochondria in this disease. We could not demonstrate a gene dosage effect in oxidation values.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2501580     DOI: 10.1007/bf01805528

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  20 in total

1.  Rapid separation of particulate components and soluble cytoplasm of isolated rat-liver cells.

Authors:  P F Zuurendonk; J M Tager
Journal:  Biochim Biophys Acta       Date:  1974-02-22

2.  Biochemical analysis of decreased ornithine transport activity in the liver mitochondria from patients with hyperornithinemia, hyperammonemia and homocitrullinuria.

Authors:  I Inoue; T Saheki; K Kayanuma; M Uono; M Nakajima; K Takeshita; R Koike; T Yuasa; T Miyatake; K Sakoda
Journal:  Biochim Biophys Acta       Date:  1988-01-12

3.  Ornithine-ketoacid transaminase activity in human skin and amniotic fluid cell culture.

Authors:  V E Shih; J D Schulman
Journal:  Clin Chim Acta       Date:  1970-01       Impact factor: 3.786

4.  Evidence for the existence of an ornithine/citrulline antiporter in rat liver mitochondria.

Authors:  N M Bradford; J D McGivan
Journal:  FEBS Lett       Date:  1980-05-05       Impact factor: 4.124

5.  Decreased transport of ornithine across the inner mitochondrial membrane as a cause of hyperornithinaemia.

Authors:  F A Hommes; C K Ho; R A Roesel; M E Coryell; B A Gordon
Journal:  J Inherit Metab Dis       Date:  1982       Impact factor: 4.982

6.  The hyperornithinemia, hyperammonemia, homocitrullinuria syndrome: an ornithine transport defect remediable with ornithine supplements.

Authors:  B A Gordon; D P Gatfield; M D Haust
Journal:  Clin Invest Med       Date:  1987-07       Impact factor: 0.825

7.  Lysinuric protein intolerance mutation is expressed in the plasma membrane of cultured skin fibroblasts.

Authors:  D W Smith; C R Scriver; H S Tenenhouse; O Simell
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

8.  Ornithine loading did not prevent induced hyperammonemia in a patient with hyperornithinemia-hyperammonemia-homocitrullinuria syndrome.

Authors:  O Simell; S Mackenzie; C L Clow; C R Scriver
Journal:  Pediatr Res       Date:  1985-12       Impact factor: 3.756

9.  Defective ornithine metabolism in cultured skin fibroblasts from patients with the syndrome of hyperornithinemia, hyperammonemia and homocitrullinuria.

Authors:  V E Shih; R Mandell; A Herzfeld
Journal:  Clin Chim Acta       Date:  1982-02-05       Impact factor: 3.786

10.  Hyperornithinemia, hyperammonemia, and homocitrullinuria. A new disorder of amino acid metabolism associated with myoclonic seizures and mental retardation.

Authors:  V E Shih; M L Efron; H W Moser
Journal:  Am J Dis Child       Date:  1969-01
View more
  1 in total

1.  The first Korean case of lysinuric protein intolerance: presented with short stature and increased somnolence.

Authors:  Jung Min Ko; Choong Ho Shin; Sei Won Yang; Moon Woo Seong; Sung Sup Park; Junghan Song
Journal:  J Korean Med Sci       Date:  2012-07-25       Impact factor: 2.153

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.